Publications by:
Claire Loiseau
Also publishes as (C. Loiseau)
Up a level |
Loiseau, Claire, Traore, Boubacar, Ongoiba, Aissata, Kayentao, Kassoum, Doumbo, Safiatou, Doumtabe, Didier, Sousa, Karina P., Brady, Jamie L., Proietti, Carla, Crompton, Peter D., and Doolan, Denise L. (2021) Memory CD8 + T cell compartment associated with delayed onset of Plasmodium falciparum infection and better parasite control in sickle‐cell trait children. Clinical & Translational Immunology, 10. e1265.
Adegboye, Oyelola, Field, Matt A., Kupz, Andreas, Pai, Saparna, Sharma, Dileep, Smout, Michael J., Wangchuk, Phurpa, Wong, Yide, and Loiseau, Claire (2021) Natural-product-based solutions for tropical infectious diseases. Clinical Microbiology Reviews, 34 (4). e00348-20.
Loiseau, Claire, Cooper, Martha M., and Doolan, Denise L. (2020) Deciphering host immunity to malaria using systems immunology. Immunological Reviews, 293 (1). pp. 115-143.
Nayrac, Manon, Requena, Mary, Loiseau, Claire, Cazabat, Michelle, Suc, Bertrand, Carrere, Nicolas, Barange, Karl, Alric, Laurent, Martin-Blondel, Guillaume, Izopet, Jacques, and Delobel, Pierre (2020) Th22 cells are efficiently recruited in the gut by CCL28 as an alternative to CCL20 but do not compensate for the loss of Th17 cells in treated HIV-1-infected individuals. Mucosal Immunology, 14. pp. 219-228.
Browne, Daniel J., Brady, Jamie L., Van Waardenberg, Ashley J., Loiseau, Claire, and Doolan, Denise L. (2020) An analytically and diagnostically sensitive RNA extraction and RT-qPCR protocol for peripheral blood mononuclear cells. Frontiers in Immunology, 11. 402.
Loiseau, Claire, Doumbo, Ogobara K, Traore, Boubacar, Brady, Jamie L., Proietti, Carla, de Sousa, Katrina P., Crompton, Peter D., and Doolan, Denise L. (2020) A novel population of memory-activated natural killer cells associated with low parasitaemia in Plasmodium falciparum-exposed sickle-cell trait children. Clinical & Translational Immunology, 9 (4). 1125.
Cooper, Martha M., Loiseau, Claire, and Doolan, Denise L. (2019) Casting a wide net around immunity to malaria catches p53. Immunity, 51 (4). pp. 603-605.
Cooper, Martha M., Loiseau, Claire, McCarthy, James S., and Doolan, Denise L. (2019) Human challenge models: tools to accelerate the development of malaria vaccines. Expert Review of Vaccines, 18 (3). pp. 241-251.
Loiseau, C., Requena, M., Nayrac, M., Mavigner, M., Cazabat, M., Iscache, A.L., Carrere, N., Suc, B., Alric, L., Izopet, J., and Delobel, P. (2019) Increase of CXCR3+ T cells impairs Th17 cells recruitment in the small intestine mucosa through IFN-g and IL-18 during treated HIV-1 infection. Journal of Infectious Diseases, 220 (5). pp. 830-840.
Loiseau, C., Requena, M., Mavigner, M., Cazabat, M., Carrere, N., Suc, B., Barange, K., Alric, L., Marchou, B., Massip, P., Izopet, J., and Delobel, P. (2016) CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunology, 9 (5). pp. 1137-1150.
Jeanne, Nicolas, Saliou, Adrien, Carcenac, Romain, Lefebvre, Caroline, Dubois, Martine, Cazabat, Michelle, Nicot, Florence, Loiseau, Claire, Raymond, Stéphanie, Izopet, Jacques, and Delobel, Pierre (2015) Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism. Scientific Reports, 5. 16944. pp. 1-10.
Loiseau, Claire, Requena, Mary, Cazabat, Michelle, Carrere, Nicolas, Suc, Bertrand, Marchou, Bruno, Izopet, Jaques, and Delobel, Pierre (2015) T regulatory cells disrupt the CCL20-CCR6 axis driving Th17 homing to the gut. In: Abstracts from the 2015 Conference on Retroviruses and Opportunistic Infections. 274. p. 235. From: CROI 2015: Conference on Retroviruses and Opportunistic Infections, 23-26 February 2015, Seattle, WA, USA.
Delobel, P., Cazabat, M., Saliou, A., Loiseau, C., Coassin, L., Raymond, S., Requena, M., Marchou, B., Massip, P., and Izopet, J. (2013) Primary resistance of CCR5-tropic HIV-1 to maraviroc cannot be predicted by the V3 sequence. Journal of Antimicrobial Chemotherapy, 68 (11). pp. 2506-2514.